Basilea Pharmaceutica (BPMUF)
(Delayed Data from OTC)
$44.45 USD
0.00 (0.00%)
Updated Apr 10, 2024 01:56 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | 2.43 |
Next Year | 2.98 |
EPS (TTM) | NA |
P/E (F1) | 18.33 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 204.70M | 231.11M |
# of Estimates | NA | NA | 2 | 1 |
High Estimate | NA | NA | 206.96M | 231.11M |
Low Estimate | NA | NA | 202.43M | 231.11M |
Year ago Sales | NA | NA | 175.50M | 204.70M |
Year over Year Growth Est. | NA | NA | 32.18% | 12.90% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 2.43 | 2.98 |
# of Estimates | NA | NA | 2 | 1 |
Most Recent Consensus | NA | NA | 2.43 | 2.98 |
High Estimate | NA | NA | 2.58 | 2.98 |
Low Estimate | NA | NA | 2.27 | 2.98 |
Year ago EPS | NA | NA | 0.96 | 2.43 |
Year over Year Growth Est. | NA | NA | 153.13% | 22.84% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 2 | 1 |
Up Last 60 Days | NA | NA | 2 | 1 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | 2.43 | 2.98 |
7 Days Ago | NA | NA | 2.43 | 2.98 |
30 Days Ago | NA | NA | 1.82 | 2.17 |
60 Days Ago | NA | NA | 1.82 | 2.17 |
90 Days Ago | NA | NA | 2.60 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | 2.43 | 2.98 |
Zacks Consensus Estimate | NA | NA | 2.43 | 2.98 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | NA | NA | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more